SAN FRANCISCO, Feb. 7, 2020 (DIAGNOSTIC WORLD) – Achieving true precision medicine in oncology continues to challenge the entire healthcare field—from clinicians to drug manufacturers to [...]

SAN FRANCISCO, Jan. 9, 2020 (DRUG TARGET REVIEW) – Modern day oncology therapies have seen significant innovation in the last decade. It is high time we commit to using biomarkers that are [...]

SAN FRANCISCO, Jan. 6, 2020 (SCRIP) – Advances in multiple scientific areas will mature into novel therapeutics, often tailored for the individual patient and increasingly curative, making [...]

SAN FRANCISCO, Dec. 16, 2019 (THE PATHOLOGIST) – Showcasing the latest techniques and technologies from industry innovators around the globe.

SAN FRANCISCO, Dec. 2, 2019 (GENENGNEWS) – Machine learning, says Cofactor Genomics, moves RNA-seq to RNA models, enables multidimensional biomarkers.

SAN FRANCISCO, Nov. 4, 2019 (FIERCEPHARMA) – Are more drugs really the answer to unlocking precision medicine? New focus that prioritizes patient profiling is likely to have major impact.

— Announces “Functional to FFPE” Early-Access Grant Program —  San Francisco — November 6, 2019 (REPORTABLE) — Cofactor Genomics, leaders in RNA-based technologies and [...]

SAN FRANCISCO, Oct. 10, 2019 (CIOREVIEW) – Drug developers and clinicians are looking for a biomarker that can capture more of a patient’s immunological profile, their response to [...]

San Francisco, September 27, 2019 (REPORTABLE) — Today Cofactor Genomics announced that it has expanded the leadership team with the promotion of Natalie LaFranzo, PhD to Vice President of [...]

Steven Daniel joins Cofactor Genomics as Vice President of Business Development — Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market   — San [...]